[{"_1":2,"_133":-5,"_134":-5},"loaderData",{"_3":4,"_9":10},"root",{"_5":6,"_7":8},"locale","id","isCms",false,"routes/tags/$slug",{"_11":12,"_13":14,"_15":16,"_120":121,"_127":123,"_131":126,"_132":-5},"slug","vaksin-convidecia","ads",[],"posts",[17],{"_6":18,"_19":20,"_11":21,"_22":23,"_24":25,"_26":27,"_28":29,"_30":31,"_32":33,"_34":35,"_36":37,"_38":39,"_40":41,"_42":43,"_44":20,"_45":46,"_47":48,"_49":50,"_51":20,"_52":53,"_54":55,"_56":57,"_58":59,"_117":118,"_68":119},"019bb76e-c9d5-7072-8064-cce96d50cd9c","title","COVID-19 – Efikasi vaksin Convidecia buatan China dekati Pfizer","covid-19-efikasi-vaksin-convidecia-buatan-china-dekati-pfizer","main_id","019bb73f-297b-7103-96b7-87ea173dc182","main_name","Iptek","main_slug","iptek-id","date","2022-06-07 19:02:34","author_id","019bb745-b426-73a2-9a49-5ddcb6765ea0","author_name","indowin","full_name","Indonesia Window","author_firstname","Indonesia","author_slug","indonesiawindow","content","Jakarta (Indonesia Window) – Tingkat efikasi vaksin Convidecia, yang diproduksi oleh perusahaan farmasi China CanSino Biologics, mampu mendekati efikasi vaksin Pfizer yang sama-sama dikembangkan melalui metode mRNA.

CanSino dalam pernyataan persnya di Beijing, Senin (6/6), menyebutkan bahwa hasil penelitian yang dilakukan di Chile menunjukkan tingkat kemanjuran satu suntikan Convidecia mencapai 95,35 persen untuk mencegah pasien dirawat di unit perawatan intensif (ICU).

Efikasinya hampir sama dengan dua dosis Pfizer yang mencapai 96,56 persen, menurut CanSino, dikutip dari Antara.

CanSino mengatakan, penelitian lain yang dilakukan di Meksiko saat negara itu terserang varian Delta pada Maret-Desember 2021, menunjukkan bahwa Convidecia mampu mencegah COVID-19 hingga 58 persen, pasien dirawat di rumah sakit (76 persen), dan kematian (48 persen).

Meskipun terjadi penurunan masa pencegahan gejala dan mutasi baru, CanSino mengatakan, satu suntikan Convidecia mampu mencegah tingkat kematian hingga 93 persen dalam waktu empat bulan setelah suntikan.

Para peneliti menganjurkan Convidecia digunakan sebagai vaksin penguat (booster) dalam menghadapi varian Omicron.

Organisasi Kesehatan Dunia (WHO) pada Mei memasukkan Convidecia sebagai vaksin yang dapat digunakan dalam situasi darurat.

Laporan: Redaksi ","excerpt","Jakarta (Indonesia Window) – Tingkat efikasi vaksin Convidecia, yang diproduksi oleh perusahaan farmasi China CanSino Biologics, mampu mendekati efikasi vaksin...","seo_kw","seo_title","","seo_description","Para peneliti menganjurkan Convidecia digunakan sebagai vaksin penguat (booster) dalam menghadapi varian Omicron.","image","2022/06/spencer-davis-4oKXRdv9x7E-unsplash-scaled.jpg","image_alt","image_caption","Ilustrasi. (Spencer Davis on Unsplash)","image_url","https://indonesiawindow.sgp1.cdn.digitaloceanspaces.com/2022/06/spencer-davis-4oKXRdv9x7E-unsplash-scaled.jpg","status","publish","tags",[60,76,83,90,97,104,111],{"_6":61,"_62":63,"_64":65,"_11":66,"_49":-5,"_67":-5,"_68":69,"_70":69,"_71":72},"019bb744-074d-735c-a3f8-0681c4bffab5","old_id",227,"name","Organisasi Kesehatan Dunia","organisasi-kesehatan-dunia","description","created_at","2026-01-13T12:10:47.000000Z","updated_at","pivot",{"_73":18,"_74":61,"_68":75,"_70":75},"post_id","tag_id","2026-01-13T12:57:29.000000Z",{"_6":77,"_62":78,"_64":79,"_11":80,"_49":-5,"_67":-5,"_68":81,"_70":81,"_71":82},"019bb744-51bf-7372-aae5-46738af3b371",7159,"efikasi Pfizer-BioNTech","efikasi-pfizer-biontech","2026-01-13T12:11:06.000000Z",{"_73":18,"_74":77,"_68":75,"_70":75},{"_6":84,"_62":85,"_64":86,"_11":87,"_49":-5,"_67":-5,"_68":88,"_70":88,"_71":89},"019bb744-6435-70f9-82b7-c1d169c84fcf",9073,"vaksin covid-19 Pfizer-BioNTech","vaksin-covid-19-pfizer-biontech","2026-01-13T12:11:11.000000Z",{"_73":18,"_74":84,"_68":75,"_70":75},{"_6":91,"_62":92,"_64":93,"_11":94,"_49":-5,"_67":-5,"_68":95,"_70":95,"_71":96},"019bb744-6790-73c5-9209-aaf5e5e4da09",9431,"varian Delta","varian-delta","2026-01-13T12:11:12.000000Z",{"_73":18,"_74":91,"_68":75,"_70":75},{"_6":98,"_62":99,"_64":100,"_11":101,"_49":-5,"_67":-5,"_68":102,"_70":102,"_71":103},"019bb744-6e4f-7165-9d57-70e8cda3b9ee",10143,"vaksin booster","vaksin-booster","2026-01-13T12:11:13.000000Z",{"_73":18,"_74":98,"_68":75,"_70":75},{"_6":105,"_62":106,"_64":107,"_11":108,"_49":-5,"_67":-5,"_68":109,"_70":109,"_71":110},"019bb744-81cb-718a-ac5e-81a90948c588",12199,"varian Omicron","varian-omicron","2026-01-13T12:11:18.000000Z",{"_73":18,"_74":105,"_68":75,"_70":75},{"_6":112,"_62":113,"_64":114,"_11":12,"_49":-5,"_67":-5,"_68":115,"_70":115,"_71":116},"019bb744-97a3-716b-95fc-4bec18d88329",14267,"vaksin Convidecia","2026-01-13T12:11:24.000000Z",{"_73":18,"_74":112,"_68":75,"_70":75},"comments",[],"2022-06-07","pagination",{"_122":123,"_124":123,"_125":126,"_127":123,"_128":123,"_129":130},"count",1,"total","perPage",12,"currentPage","totalPages","links",{},"pageSize","error","actionData","errors"]